SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Coupang, Inc. (CPNG) trades at a trailing P/E of 173.7, forward P/E of 328.4. Trailing earnings yield is 0.58%, forward earnings yield 0.30%. PEG 5.70. Graham Number is $2.56.
Criteria proven by this page:
- VALUE (71/100, Pass) — analyst target implies upside (+21.6%).
- PEG Ratio 5.70 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 0.58% — below bond yields — investors are paying a premium for expected growth rather than current earnings.
- Analyst consensus target $25.20 (+21.6% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 68/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
71/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CPNG
Valuation Multiples
P/E (TTM)173.7
Forward P/E328.4
PEG Ratio5.70
Forward PEG2.47
P/B Ratio7.82
P/S Ratio1.05
EV/EBITDA50.7
Per Share Data
EPS (TTM)$0.11
Forward EPS (Est.)$0.06
Book Value / Share$2.54
Revenue / Share$19.00
FCF / Share$0.28
Yields & Fair Value
Earnings Yield0.58%
Forward Earnings Yield0.30%
Dividend Yield0.00%
Graham Number$2.56
SharesGrow IV$362.90 (+1651.4%)
Analyst Target$25.20 (+21.6%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2018 |
-71.8 |
0.00 |
-104.69 |
19.44 |
- |
| 2019 |
-113.1 |
3.71 |
-22.30 |
12.56 |
- |
| 2020 |
-181.5 |
5.81 |
-20.66 |
7.02 |
- |
| 2021 |
-27.1 |
-0.12 |
19.23 |
2.27 |
- |
| 2022 |
-282.1 |
2.96 |
10.75 |
1.26 |
- |
| 2023 |
21.2 |
-0.01 |
7.06 |
1.18 |
- |
| 2024 |
256.1 |
-2.89 |
9.61 |
1.30 |
- |
| 2025 |
206.2 |
7.31 |
9.28 |
1.24 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$-0.69 |
$4.05B |
$-1.1B |
-27.1% |
| 2019 |
$-0.40 |
$6.27B |
$-696.89M |
-11.1% |
| 2020 |
$-0.27 |
$11.97B |
$-474.9M |
-4% |
| 2021 |
$-1.08 |
$18.41B |
$-1.54B |
-8.4% |
| 2022 |
$-0.05 |
$20.58B |
$-92.04M |
-0.4% |
| 2023 |
$0.75 |
$24.38B |
$1.36B |
5.6% |
| 2024 |
$0.08 |
$30.27B |
$154M |
0.5% |
| 2025 |
$0.11 |
$34.53B |
$208M |
0.6% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.06 |
$0.00 – $0.22 |
$38.26B |
$34.68B – $39.55B |
4 |
| 2027 |
$0.56 |
$0.50 – $0.59 |
$43.44B |
$38.26B – $45.65B |
7 |
| 2028 |
$0.88 |
$0.64 – $1.18 |
$47.47B |
$46.88B – $48.06B |
6 |
| 2029 |
$0.80 |
$0.67 – $0.87 |
$48.65B |
$42.75B – $52.26B |
4 |
